US Stock MarketDetailed Quotes

CLVS Clovis Oncology

Watchlist

0.0812
0.00000.00%

Close Dec 20 16:00 ET

11.77MMarket Cap-44P/E (TTM)

Clovis Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

11.85%-40.61M

24.87%-35.13M

5.49%-58.5M

22.42%-196.06M

26.24%-41.34M

15.20%-46.07M

21.89%-46.76M

24.98%-61.89M

21.90%-252.73M

20.09%-56.05M

Net income from continuing operations

16.90%-56.02M

-7.35%-71.33M

9.22%-60.17M

28.35%-264.52M

34.93%-64.39M

14.32%-67.41M

27.97%-66.45M

33.28%-66.28M

7.79%-369.21M

0.55%-98.96M

Operating gains losses

----

117.73%3.28M

--0

Depreciation and amortization

-6.53%1.89M

-14.93%1.9M

-14.19%1.92M

3.64%8.5M

-2.58%2M

0.05%2.02M

11.96%2.24M

5.21%2.24M

5.54%8.2M

0.49%2.05M

Other non cash items

11,587.50%935K

-42.86%944K

-38.92%926K

-88.85%4.25M

-96.21%1.07M

-98.76%8K

159.34%1.65M

-82.32%1.52M

44.22%38.09M

459.68%28.23M

Change In working capital

-49.68%6.2M

116.10%18.24M

-129.01%-7.81M

153.17%30.27M

2,069.13%12.93M

33.86%12.31M

-31.97%8.44M

66.73%-3.41M

43.56%11.96M

-97.48%596K

-Change in receivables

3.52%-1.86M

437.23%8.1M

-116.17%-765K

86.20%-746K

79.99%-1.15M

5.48%-1.93M

-134.91%-2.4M

204.71%4.73M

28.08%-5.41M

-60.46%-5.72M

-Change in inventory

95.09%4.81M

95.03%5.58M

0.55%3.69M

136.31%12.57M

206.31%3.59M

-43.21%2.46M

215.23%2.86M

-46.41%3.67M

120.34%5.32M

-5.14%-3.37M

-Change in prepaid assets

-251.79%-2.88M

-110.57%-8.13M

-162.26%-1.32M

38.79%-5.09M

-12,113.95%-5.25M

164.58%1.9M

-130.63%-3.86M

111.85%2.13M

-135.78%-8.31M

-100.43%-43K

-Change in payables and accrued expense

-68.45%3.2M

-28.68%7.7M

49.31%-4.53M

177.92%26.47M

306.69%14.47M

-8.65%10.13M

304.31%10.8M

-5,381.66%-8.93M

-62.81%9.53M

-83.32%3.56M

-Change in other working capital

1,291.50%2.94M

379.27%4.99M

2.52%-4.88M

-127.15%-2.94M

-79.45%1.27M

80.08%-247K

49.50%1.04M

-196.29%-5.01M

258.42%10.83M

819.81%6.18M

Cash from discontinued investing activities

Operating cash flow

11.85%-40.61M

24.87%-35.13M

5.49%-58.5M

22.42%-196.06M

26.24%-41.34M

15.20%-46.07M

21.89%-46.76M

24.98%-61.89M

21.90%-252.73M

20.09%-56.05M

Investing cash flow

Cash flow from continuing investing activities

0.00%-89K

-27.78%-46K

47.46%-62K

-100.25%-312K

73.46%-69K

-368.42%-89K

-100.06%-36K

-100.17%-118K

-11.90%126.33M

-101.55%-260K

Net PPE purchase and sale

0.00%-89K

-27.78%-46K

47.46%-62K

11.86%-312K

73.46%-69K

-368.42%-89K

12.20%-36K

-247.06%-118K

88.26%-354K

35.48%-260K

Net intangibles purchase and sale

----

--0

----

49.21%-8M

--0

Net investment purchase and sale

----

--0

----

-16.95%134.68M

--0

Cash from discontinued investing activities

Investing cash flow

0.00%-89K

-27.78%-46K

47.46%-62K

-100.25%-312K

73.46%-69K

-368.42%-89K

-100.06%-36K

-100.17%-118K

-11.90%126.33M

-101.55%-260K

Financing cash flow

Cash flow from continuing financing activities

150.12%6.18M

-89.36%9.14M

183.02%37.86M

-50.82%100.16M

-81.67%13.17M

-176.29%-12.33M

-14.92%85.94M

-8.66%13.38M

69.86%203.64M

443.96%71.84M

Net issuance payments of debt

111.47%6.18M

-31.63%8.76M

-30.92%9.22M

59.56%-17.95M

-86.36%9.73M

-432.03%-53.84M

-26.01%12.81M

108.94%13.35M

-138.06%-44.39M

472.29%71.34M

Net common stock issuance

--0

-100.01%-8K

--28.64M

-52.60%116.92M

--2.94M

70,466.10%41.52M

-12.50%72.47M

--0

--246.67M

--0

Proceeds from stock option exercised by employees

--0

-40.24%392K

--0

-13.22%1.18M

1.01%499K

--0

-24.25%656K

1,250.00%27K

-58.30%1.36M

-33.24%494K

Cash from discontinued financing activities

Financing cash flow

150.12%6.18M

-89.36%9.14M

183.02%37.86M

-50.82%100.16M

-81.67%13.17M

-176.29%-12.33M

-14.92%85.94M

-8.66%13.38M

69.86%203.64M

443.96%71.84M

Net cash flow

Beginning cash position

-58.92%94.58M

-35.97%122.24M

-40.30%143.43M

48.44%240.23M

-23.48%171.95M

-11.95%230.2M

16.91%190.92M

48.44%240.23M

-27.06%161.83M

11.53%224.7M

Current changes in cash

40.97%-34.52M

-166.49%-26.03M

57.44%-20.7M

-224.56%-96.21M

-281.96%-28.25M

-53.16%-58.48M

-60.03%39.15M

-2,585.03%-48.63M

228.04%77.24M

138.64%15.52M

Effect of exchange rate changes

-858.95%-1.74M

-1,327.82%-1.63M

27.85%-487K

-151.13%-589K

-7,000.00%-276K

-84.23%229K

-24.86%133K

-40.33%-675K

302.80%1.15M

-99.24%4K

End cash Position

-66.08%58.32M

-58.92%94.58M

-35.97%122.24M

-40.30%143.43M

-23.48%171.95M

-11.95%230.2M

16.91%190.92M

48.44%240.23M

Free cash flow

11.83%-40.7M

24.83%-35.17M

5.57%-58.56M

24.79%-196.37M

26.46%-41.41M

15.06%-46.16M

31.09%-46.79M

24.86%-62.01M

23.81%-261.08M

20.18%-56.31M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	11.85%-40.61M	24.87%-35.13M	5.49%-58.5M	22.42%-196.06M	26.24%-41.34M	15.20%-46.07M	21.89%-46.76M	24.98%-61.89M	21.90%-252.73M	20.09%-56.05M
Net income from continuing operations	16.90%-56.02M	-7.35%-71.33M	9.22%-60.17M	28.35%-264.52M	34.93%-64.39M	14.32%-67.41M	27.97%-66.45M	33.28%-66.28M	7.79%-369.21M	0.55%-98.96M
Operating gains losses	----	----	----	----	----	----	----	----	117.73%3.28M	--0
Depreciation and amortization	-6.53%1.89M	-14.93%1.9M	-14.19%1.92M	3.64%8.5M	-2.58%2M	0.05%2.02M	11.96%2.24M	5.21%2.24M	5.54%8.2M	0.49%2.05M
Other non cash items	11,587.50%935K	-42.86%944K	-38.92%926K	-88.85%4.25M	-96.21%1.07M	-98.76%8K	159.34%1.65M	-82.32%1.52M	44.22%38.09M	459.68%28.23M
Change In working capital	-49.68%6.2M	116.10%18.24M	-129.01%-7.81M	153.17%30.27M	2,069.13%12.93M	33.86%12.31M	-31.97%8.44M	66.73%-3.41M	43.56%11.96M	-97.48%596K
-Change in receivables	3.52%-1.86M	437.23%8.1M	-116.17%-765K	86.20%-746K	79.99%-1.15M	5.48%-1.93M	-134.91%-2.4M	204.71%4.73M	28.08%-5.41M	-60.46%-5.72M
-Change in inventory	95.09%4.81M	95.03%5.58M	0.55%3.69M	136.31%12.57M	206.31%3.59M	-43.21%2.46M	215.23%2.86M	-46.41%3.67M	120.34%5.32M	-5.14%-3.37M
-Change in prepaid assets	-251.79%-2.88M	-110.57%-8.13M	-162.26%-1.32M	38.79%-5.09M	-12,113.95%-5.25M	164.58%1.9M	-130.63%-3.86M	111.85%2.13M	-135.78%-8.31M	-100.43%-43K
-Change in payables and accrued expense	-68.45%3.2M	-28.68%7.7M	49.31%-4.53M	177.92%26.47M	306.69%14.47M	-8.65%10.13M	304.31%10.8M	-5,381.66%-8.93M	-62.81%9.53M	-83.32%3.56M
-Change in other working capital	1,291.50%2.94M	379.27%4.99M	2.52%-4.88M	-127.15%-2.94M	-79.45%1.27M	80.08%-247K	49.50%1.04M	-196.29%-5.01M	258.42%10.83M	819.81%6.18M
Cash from discontinued investing activities
Operating cash flow	11.85%-40.61M	24.87%-35.13M	5.49%-58.5M	22.42%-196.06M	26.24%-41.34M	15.20%-46.07M	21.89%-46.76M	24.98%-61.89M	21.90%-252.73M	20.09%-56.05M
Investing cash flow
Cash flow from continuing investing activities	0.00%-89K	-27.78%-46K	47.46%-62K	-100.25%-312K	73.46%-69K	-368.42%-89K	-100.06%-36K	-100.17%-118K	-11.90%126.33M	-101.55%-260K
Net PPE purchase and sale	0.00%-89K	-27.78%-46K	47.46%-62K	11.86%-312K	73.46%-69K	-368.42%-89K	12.20%-36K	-247.06%-118K	88.26%-354K	35.48%-260K
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	49.21%-8M	--0
Net investment purchase and sale	----	----	----	--0	----	----	----	----	-16.95%134.68M	--0
Cash from discontinued investing activities
Investing cash flow	0.00%-89K	-27.78%-46K	47.46%-62K	-100.25%-312K	73.46%-69K	-368.42%-89K	-100.06%-36K	-100.17%-118K	-11.90%126.33M	-101.55%-260K
Financing cash flow
Cash flow from continuing financing activities	150.12%6.18M	-89.36%9.14M	183.02%37.86M	-50.82%100.16M	-81.67%13.17M	-176.29%-12.33M	-14.92%85.94M	-8.66%13.38M	69.86%203.64M	443.96%71.84M
Net issuance payments of debt	111.47%6.18M	-31.63%8.76M	-30.92%9.22M	59.56%-17.95M	-86.36%9.73M	-432.03%-53.84M	-26.01%12.81M	108.94%13.35M	-138.06%-44.39M	472.29%71.34M
Net common stock issuance	--0	-100.01%-8K	--28.64M	-52.60%116.92M	--2.94M	70,466.10%41.52M	-12.50%72.47M	--0	--246.67M	--0
Proceeds from stock option exercised by employees	--0	-40.24%392K	--0	-13.22%1.18M	1.01%499K	--0	-24.25%656K	1,250.00%27K	-58.30%1.36M	-33.24%494K
Cash from discontinued financing activities
Financing cash flow	150.12%6.18M	-89.36%9.14M	183.02%37.86M	-50.82%100.16M	-81.67%13.17M	-176.29%-12.33M	-14.92%85.94M	-8.66%13.38M	69.86%203.64M	443.96%71.84M
Net cash flow
Beginning cash position	-58.92%94.58M	-35.97%122.24M	-40.30%143.43M	48.44%240.23M	-23.48%171.95M	-11.95%230.2M	16.91%190.92M	48.44%240.23M	-27.06%161.83M	11.53%224.7M
Current changes in cash	40.97%-34.52M	-166.49%-26.03M	57.44%-20.7M	-224.56%-96.21M	-281.96%-28.25M	-53.16%-58.48M	-60.03%39.15M	-2,585.03%-48.63M	228.04%77.24M	138.64%15.52M
Effect of exchange rate changes	-858.95%-1.74M	-1,327.82%-1.63M	27.85%-487K	-151.13%-589K	-7,000.00%-276K	-84.23%229K	-24.86%133K	-40.33%-675K	302.80%1.15M	-99.24%4K
End cash Position	-66.08%58.32M	-58.92%94.58M	-35.97%122.24M	-40.30%143.43M	-40.30%143.43M	-23.48%171.95M	-11.95%230.2M	16.91%190.92M	48.44%240.23M	48.44%240.23M
Free cash flow	11.83%-40.7M	24.83%-35.17M	5.57%-58.56M	24.79%-196.37M	26.46%-41.41M	15.06%-46.16M	31.09%-46.79M	24.86%-62.01M	23.81%-261.08M	20.18%-56.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall